hotspot -WSS

hotspot

author：fashion 2025-09-05 09:11:36 - browse：29

Japanese drugmaker Eisai said Tuesday that Ivan Cheung, chairman of its U.S. operations and global head of its Alzheimer’s disease unit, will retire at the end of the month. The surprise announcement comes just days after Eisai won final approval in the U.S. for its Alzheimer’s drug Leqembi.

Cheung will be replaced in his capacity as head of the Alzheimer’s unit by his brother-in-law Keisuke Naito, 34, who is currently chief ecosystem officer and chief strategy officer. He is also the son of Eisai CEO Haruo Naito.

Tatsuyuki Yasuno, current chief financial officer, will replace Cheung as head of Eisai’s U.S. unit.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： CDC advisory panel says seniors 'may' get RSV vaccine

focus

WSS

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

PrEP can help anyone prevent HIV. Why do so few people take it?

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Winners, losers from Medicare’s list of drugs subject to price talks

Diversity in medical illustrations gets boost from Chidiebere Ibe

focus

hotspot

focus

Bright Health sells Medicare Advantage business to Molina

Transgender women dream of pregnancy via uterus transplants

Medical records are filled with copy

Why more medical students aren't specializing in primary care

Hepatitis C has a cure — but many Americans still lack access to it

Radiation, mainstay of cancer treatment, begins a fade

Bright Health sells Medicare Advantage business to Molina

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

Moonlake's readout produced a cash windfall. Risks remain

Severe heat forecast: Where scorching temperatures will persist over the next week

knowledge

Winners, losers from Medicare’s list of drugs subject to price talks

Doctors have an ethical obligation to be advocates

Severe heat forecast: Where scorching temperatures will persist over the next week

PrEP can help anyone prevent HIV. Why do so few people take it?

Complete sequence of Y chromosome published for first time

AstraZeneca bets AAV gene therapy will still deliver the goods

leisure time

focus

leisure time

leisure time